Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15989 | TPP | 12/12 | Linda Nab | 3 years, 6 months ago 03 March 2023 15:32:02 UTC | View, Job request 15989 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15988 | TPP | 1/1 | Linda Nab | 3 years, 6 months ago 03 March 2023 15:03:18 UTC | View, Job request 15988 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15987 | TPP | 32/32 | Linda Nab | 3 years, 6 months ago 03 March 2023 14:44:39 UTC | View, Job request 15987 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15981 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 03 March 2023 08:56:24 UTC | View, Job request 15981 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15980 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 03 March 2023 08:50:28 UTC | View, Job request 15980 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15979 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 03 March 2023 08:32:22 UTC | View, Job request 15979 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15977 | TPP | 1/2 | Bang Zheng | 3 years, 6 months ago 03 March 2023 00:21:22 UTC | View, Job request 15977 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15976 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 02 March 2023 23:52:50 UTC | View, Job request 15976 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15975 | TPP | 12/12 | Linda Nab | 3 years, 6 months ago 02 March 2023 23:47:51 UTC | View, Job request 15975 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15974 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 02 March 2023 23:38:31 UTC | View, Job request 15974 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15973 | TPP | 2/2 | Linda Nab | 3 years, 6 months ago 02 March 2023 23:32:47 UTC | View, Job request 15973 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15972 | TPP | 1/2 | Bang Zheng | 3 years, 6 months ago 02 March 2023 23:31:37 UTC | View, Job request 15972 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15971 | TPP | 5/5 | Linda Nab | 3 years, 6 months ago 02 March 2023 23:31:21 UTC | View, Job request 15971 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15970 | TPP | 3/3 | Linda Nab | 3 years, 6 months ago 02 March 2023 23:28:27 UTC | View, Job request 15970 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15969 | TPP | 2/3 | Linda Nab | 3 years, 6 months ago 02 March 2023 23:06:48 UTC | View, Job request 15969 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15968 | TPP | 1/1 | Bang Zheng | 3 years, 6 months ago 02 March 2023 22:40:24 UTC | View, Job request 15968 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15967 | TPP | 4/4 | Linda Nab | 3 years, 6 months ago 02 March 2023 22:37:16 UTC | View, Job request 15967 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15966 | TPP | 0/1 | Bang Zheng | 3 years, 6 months ago 02 March 2023 22:37:05 UTC | View, Job request 15966 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15965 | TPP | 1/1 | Linda Nab | 3 years, 6 months ago 02 March 2023 22:34:43 UTC | View, Job request 15965 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15964 | TPP | 1/1 | Linda Nab | 3 years, 6 months ago 02 March 2023 22:29:28 UTC | View, Job request 15964 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15963 | TPP | 4/4 | Linda Nab | 3 years, 6 months ago 02 March 2023 21:53:21 UTC | View, Job request 15963 |
| Failed | OpenSAFELY Internal | opensafely-internal-interactive | 15962 | TPP | 8/9 | Lucy Bridges | 3 years, 6 months ago 02 March 2023 17:55:27 UTC | View, Job request 15962 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15961 | TPP | 1/1 | Linda Nab | 3 years, 6 months ago 02 March 2023 17:42:37 UTC | View, Job request 15961 |
| Succeeded | OpenSAFELY Internal | opensafely-internal-interactive | 15960 | TPP | 10/10 | Brian Mackenna (Gmail) | 3 years, 6 months ago 02 March 2023 16:15:30 UTC | View, Job request 15960 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15959 | TPP | 1/1 | Linda Nab | 3 years, 6 months ago 02 March 2023 16:39:43 UTC | View, Job request 15959 |